Mara Mardare

Clinical Emergency Hospital Bucharest

Papers

1

Total Citations

64

H-Index

1

About

Dr. Mara Mardare is a leading researcher at the intersection of oncology, liquid biopsy, and artificial intelligence, whose work is redefining early cancer detection and patient stratification. Her most cited study, "Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies" (2022, 64 citations), exemplifies her major contribution: integrating AI-driven analysis of circulating biomarkers to identify colorectal cancer signatures non-invasively. This work directly addresses the critical challenge of late-stage diagnosis in colorectal cancer—the second most common cancer worldwide—by enabling earlier, more precise detection. Dr. Mardare’s research demonstrates how machine learning can decode complex biological data from liquid biopsies, moving beyond traditional screening to stratify patients by risk and disease stage. Her innovative approach has garnered significant attention, with her top-cited paper already influencing the field’s shift toward personalized, data-driven oncology. By bridging computational methods with clinical needs, Dr. Mardare is pioneering a modern framework for cancer management, where artificial intelligence and minimally invasive tools converge to improve prognosis and treatment outcomes. Her work stands as a vital resource for students and researchers seeking to understand the future of precision medicine in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
64 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Clinical Emergency Hospital Bucharest

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago